Repurposing pharmaceuticals : does united states intellectual property law and regulatory policy assign sufficienct value to new use patents?
Year of publication: |
2012
|
---|---|
Authors: | Hemphill, Thomas A. |
Published in: |
International journal of innovation management. - Singapore : World Scientific Publ., ISSN 1363-9196, ZDB-ID 1339582-8. - Vol. 16.2012, 4, p. 1-17
|
Subject: | Immaterialgüterrechte | Intellectual property rights | Regulierung | Regulation | Patent | Innovationsmanagement | Innovation management | Arzneimittel | Pharmaceuticals | USA | United States |
-
Nasu, Hitoshi, (2010)
-
United States Special 301 : a deeply flawed tool for IPR regulation?
Qureshi, Asif H., (2021)
-
Diversity management of patents in M&A : a case of Japanese pharmaceutical firms
Shimanuki, Seiya, (2012)
- More ...
-
Wholly owned foreign subsidiary relation-based strategies in volatile environments
White, George O., (2014)
-
The business method patent: a barrier to global harmonisation of intellectual property rights?
Hemphill, Thomas A., (2006)
-
Hemphill, Thomas A., (2012)
- More ...